A vaccine for pancreatic cancer shows promising results - Al-Bilad Saudi newspaper. Albilad (Agencies) Researchers said: An experimental vaccine targeting one of the most common genetic factors for pancreatic cancer succeeded in preventing the development of the disease in patients at high risk in a preliminary trial.
An experimental vaccine to prevent pancreatic tumor achieves promising results in the first trial on humans in America Cairo 24 Promising results for the MSN pancreatic cancer vaccine An experimental vaccine that creates “immune memory” against pancreatic cancer.
Details
20 participants at high genetic risk for pancreatic cancer and who had a pancreatic disorder detected through imaging tests received four doses of the vaccine over 13 weeks.
Kerase mutations are found in most cases of pancreatic cancer and early precancerous lesions
An experimental vaccine to prevent pancreatic tumor achieves promising results in the first human trial in America.
An experimental vaccine to prevent pancreatic tumor achieves promising results in the first human trial in America.
20 participants at high genetic risk for pancreatic cancer and who had a pancreatic disorder detected through imaging tests received four doses of the vaccine over 13 weeks.
Context
Kerase mutations are found in most cases of pancreatic cancer and early precancerous lesions
An experimental vaccine to prevent pancreatic tumor achieves promising results in the first human trial in America
Albilad (Agencies) Researchers said: An experimental vaccine targeting one of the most common genetic factors for pancreatic cancer succeeded in preventing the development of the disease in patients at high risk in a preliminary trial.
What to watch next
Kerase mutations are found in most cases of pancreatic cancer and early precancerous lesions.
